Key Points
- Insider Gary Guthart sold 22,806 shares on Dec. 1 at an average of $570.89 for about $13.02 million, leaving him with 2,694 shares — an 89.44% reduction in his ownership.
- Intuitive Surgical recently beat expectations with EPS of $2.40 (vs. $1.99 est.) and revenue of $2.51 billion, up 22.9% year‑over‑year.
- The stock trades near $567.72 (1‑year range $425–$616) with a market cap of ~$203.5B and a PE of ~75, and analysts rate it a Moderate Buy with an average target of $607.28.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) insider Gary Guthart sold 22,806 shares of the firm's stock in a transaction on Monday, December 1st. The stock was sold at an average price of $570.89, for a total value of $13,019,717.34. Following the completion of the transaction, the insider owned 2,694 shares in the company, valued at approximately $1,537,977.66. This trade represents a 89.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Intuitive Surgical Stock Performance
Intuitive Surgical stock opened at $567.72 on Wednesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock has a fifty day moving average of $510.79 and a 200 day moving average of $504.70. The stock has a market cap of $203.51 billion, a PE ratio of 75.10, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analysts' expectations of $2.41 billion. During the same period last year, the firm posted $1.84 earnings per share. The business's revenue for the quarter was up 22.9% on a year-over-year basis. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of ISRG. Tobam raised its holdings in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 40 shares during the period. Kilter Group LLC purchased a new stake in shares of Intuitive Surgical during the second quarter worth about $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $27,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
Analyst Ratings Changes
Several brokerages recently issued reports on ISRG. Leerink Partners boosted their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an "outperform" rating in a research report on Wednesday, October 22nd. Hsbc Global Res raised shares of Intuitive Surgical to a "strong-buy" rating in a research report on Thursday, October 23rd. The Goldman Sachs Group upped their price objective on Intuitive Surgical from $567.00 to $621.00 and gave the stock a "buy" rating in a research note on Wednesday, October 22nd. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a "buy" rating in a research report on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $607.28.
Get Our Latest Analysis on ISRG
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
